- Small-cap seed stock surges: Origin Agritech (NASDAQ: SEED) nearly doubled in after-hours trading, jumping +92% on Oct. 14 after bullish news – spiking from around $1.44 to roughly $2.76 overnight [1]. As of Oct. 15, shares hovered near $1.43, up ~27% in a month but still down ~32% year-to-date [2].
- China market re-entry: The Beijing-based agri-tech firm re-entered Northeast China, hosting a product showcase that drew 200+ seed dealers and partners and marked a return to a key corn-growing region [3]. Origin introduced newly approved hybrid corn varieties (e.g. Jinqiao 8, Jingke 4580, Jingke 317) touted for high yields and disease resistance [4]. Executives say these seeds will be “significant drivers” of future revenue [5].
- New deals & tech advances: Origin unveiled a strategic partnership with Fengtian Seed Industry to co-develop premium corn hybrids (Ao Yu Feng Tian series) and leverage Fengtian’s distribution network [6] [7]. The company also highlighted R&D breakthroughs – its BBL2-2 genetically modified corn trait (insect- and herbicide-resistant) and new gene-edited high-yield lines – signaling a robust biotech pipeline [8] [9].
- CEO invests in growth: In late September, Origin’s CEO Weibin Yan personally invested $2.4 million into the company (buying 2 million shares at $1.20 each), a strong vote of confidence [10]. Institutional investors added another $1.48 million under revised agreements, bolstering the cash reserves for expansion [11] [12]. Yan said these infusions show “strong commitment” to Origin’s long-term strategy and provide “important capital” to execute growth plans [13].
- Sector-wide rally on trade news:Agriculture and biotech stocks spiked across the board this week after a U.S. trade threat against China. Origin’s 92% after-hours leap coincided with President Trump’s post vowing to cut Chinese cooking-oil imports – a surprise move that sent traders snapping up small-cap agri names [14] [15]. Peers Arcadia Biosciences (RKDA) rose 53% and Australian Oilseeds (COOT) rocketed 248% on the chatter [16]. Experts cautioned the frenzy was speculative, noting the actual trade impact is limited [17].
- Cautious optimism ahead: Analysts see huge opportunities as China modernizes farming and embraces GMO crops, but also note substantial risks. Origin’s new products and partnerships position it to ride China’s pro-biotech push, yet converting R&D wins into sales will be critical. The firm remains a micro-cap (~$11 million market value [18]) with ongoing losses, and earlier this year auditors raised a “going concern” warning about its need for capital. Bottom line: SEED’s long-term outlook hinges on execution – delivering on its pipeline, scaling production, and navigating policy – even as the recent stock hype injects fresh momentum into this agritech innovator.
SEED Stock Soars on Market Momentum
Origin Agritech’s stock skyrocketed this week, delivering eye-popping gains for investors. On Tuesday night, SEED shares surged over 92% in after-hours trading following a flurry of positive developments [19]. The price spiked from the $1.40 range to roughly $2.76 in extended trading – nearly a doubling overnight. By Wednesday Oct. 15, the stock opened sharply higher before paring back to about $1.43 by mid-day [20], roughly flat from Tuesday’s official close of $1.44 [21].
This explosive move came amid a broader rally in agricultural and biotech shares. U.S. political news turbocharged the sector: a high-profile threat by President Trump to “terminate business with China” on certain farm products set off a speculative frenzy [22]. Traders piled into small-cap agri-tech names, sending several soaring in tandem. Origin’s 92% jump was accompanied by outsized gains in peers like Arcadia Biosciences (up 53% after hours) and Australian Oilseeds (up 248%) as the market bet on companies that might benefit from trade disruptions [23].
“The sector-wide rally was driven by political headlines rather than fundamentals,” one market expert observed, noting that U.S. imports of Chinese cooking oil were already minimal [24]. Analysts cautioned that the dramatic spike in SEED and its peers may not be sustainable without concrete improvements in business performance [25]. Still, the speculative jolt has put a spotlight on Origin Agritech just as the company unveils encouraging news of its own.
Even before the latest jump, SEED’s stock had been mounting a comeback in recent weeks. The share price climbed ~27% over the past month [26], reflecting growing optimism around the company’s initiatives (detailed below). Year-to-date, however, SEED remains down about 32% [27], as earlier financing challenges and market volatility took a toll. The stock has traded in a wide 52-week range from a low of just $0.74 during the summer to a high of $3.11 last fall [28]. This volatility underlines SEED’s profile as a high-risk, high-reward microcap. With only ~68 employees and a market capitalization near $11 million [29] [30], Origin Agritech’s stock can swing wildly on news catalysts and low trading volumes. Technical indicators recently flashed a “Strong Buy” signal on SEED shares [31] thanks to the upward momentum. Now, the question for investors is whether the company’s fundamentals can justify and sustain this renewed market enthusiasm.
China Comeback: New Corn Varieties Fuel Growth Hopes
Origin Agritech is seizing a pivotal opportunity in China’s agricultural market. The company has executed a re-entry into Northeast China, a key corn-growing region, after years of limited presence there. In mid-September, Origin hosted a high-profile Variety Showcase and Technology Seminar in Changchun, Jilin Province – effectively relaunching its products in the vital Northeast corn belt [32]. The event drew over 200 local seed dealers and partners, underscoring strong distributor interest as Origin expands its footprint.
At the showcase, Origin introduced several new hybrid corn varieties that recently earned national approval in China [33]. These include premium breeds like Jinqiao 8, Jingke 4580, and Jingke 317. Each offers improved agronomic traits – from high yield potential to robust disease resistance and climate adaptability [34]. Origin’s team believes these advanced seeds can significantly boost farm productivity and will become “significant drivers of future revenue” as they roll out commercially [35]. Notably, gaining regulatory approval for new hybrids in China is a major milestone that reduces barriers to sales. It suggests Origin’s R&D investments are bearing fruit in tangible products ready for market.
The Northeast China push is part of Origin’s broader strategy to reinvigorate domestic sales. By reconnecting with regional distributors and showcasing an updated product lineup, the company is rebuilding channels in an area historically dubbed China’s “corn basket.” The enthusiastic response from dealers at the Changchun event bodes well. “Our re-entry into the Northeast market is a pivotal part of our growth strategy,” said Origin CEO Weibin Yan, noting that over 200 key partners attended and “validated our product strategy” with their strong reception [36]. This foothold lays a foundation for accelerating seed sales in the coming planting seasons.
In addition to new products, Origin is sweetening its channel relationships through innovative programs. The company recently launched a “Golden Harvest Club” and a Brand Symbiosis Program for its dealers [37]. These initiatives offer incentives, training, and co-branding opportunities to strengthen loyalty among distributors. By deepening its partner network and support, Origin aims to drive faster market penetration for its seeds – a crucial step as competition in China’s seed market heats up.
Strategic Partnerships and Tech Breakthroughs
Origin Agritech’s resurgence is being powered not just by seeds, but by strategic alliances and cutting-edge biotech. A headline announcement this week is Origin’s new collaboration with Fengtian Seed Industry, a regional seed powerhouse. The agreement will see Origin and Fengtian co-develop and commercialize select premium corn hybrids – specifically, varieties branded Ao Yu Feng Tian 310, 501, and 109 [38]. By tapping Fengtian’s established distribution networks in Northeast China, Origin gains ready access to thousands of local retailers and farmers. This “partnership model” accelerates Origin’s market penetration by leveraging a partner’s on-the-ground reach [39]. In return, Fengtian enriches its portfolio with Origin’s proprietary, high-performance seeds. Such win-win alliances are vital for a smaller company like Origin to scale up in a fragmented market.
Importantly, Origin continues to distinguish itself through biotechnology innovations. At the recent seminar, the company’s R&D Director Bill Deng highlighted advances in Origin’s transgenic (GMO) pipeline, especially the progress of its flagship BBL2-2 corn trait [40]. BBL2-2 is a genetically modified corn event that carries a “triple-stack” of traits – two insect resistance genes and one herbicide tolerance gene – to protect against pests like corn borers and to tolerate glyphosate herbicide [41]. This biotech trait is a big deal: it was the first transgenic corn approved in China (granted a GMO biosafety certificate in 2024) and promises farmers higher yields with fewer losses [42] [43]. Origin’s team reported that commercial rollout of BBL2-2 maize is now underway, with multiple hybrid versions containing this trait in national trial stages [44]. One BBL2-2 hybrid is on track for potential final approval by the end of 2025, and two more by 2026 [45] – a pipeline that could position Origin among the first to market GMO corn seeds in China.
Origin’s fully automated seed processing facility in Xinjiang began full-scale operations in 2025, boosting production capacity with advanced sorting, coating, and packaging technologies [46] [47].
Beyond transgenics, Origin is also riding the wave of gene editing to develop the next generation of crops. At the Changchun event, Professor Feng Tian of China Agricultural University (a research partner) showcased new gene-edited corn varieties created with Origin [48] [49]. For example, Origin has deployed CRISPR/Cas-based techniques to create a high-yield corn inbred line that showed a remarkable 50% yield boost in field trials [50]. These gene-edited traits (which modify a plant’s own genes without foreign DNA) are advancing through China’s approval pipeline as well [51]. Such innovations could be game-changing in a country seeking to increase output on limited arable land.
Origin’s research partnerships with top institutions amplify its technical edge. Earlier this year, the company formed a three-way R&D alliance with China Agricultural University and Beijing Academy of Agricultural & Forestry Sciences [52]. This coalition focuses on “smart plant” breeding – merging big data, precision gene markers, and breeding expertise to design superior corn strains [53]. Origin also partnered with dozens of local breeding companies via a Marker Biological Breeding Consortium to spread its GMO and gene-editing technologies nationwide [54]. The upshot is that Origin is plugging into China’s broader innovation ecosystem, which should hasten the adoption of its biotech traits across many corn varieties and regions.
Crucially, the Chinese policy climate is turning more supportive for agri-tech innovation. In recent years, China’s government called for an urgent “turnaround” in the seed industry, recognizing that domestic seed innovation lagged global standards [55] [56]. Regulators have since streamlined GMO crop approval rules to pave the way for GM corn commercialization [57]. “It clarifies the procedures for GMO variety approvals and simplifies the process… It will accelerate GMO corn commercial production,” noted Dr. Gengchen Han, Origin’s chairman, when new rules were drafted [58]. This regulatory green light is why Origin’s BBL2-2 trait finally obtained a safety certificate in 2024 after a decade of R&D. As China moves to approve biotech crops for planting, Origin stands to benefit as a first-mover with proven GMO products. Analysts estimate China could eventually plant up to 33 million hectares of GM corn, yielding ¥5 billion (≈$700 million) in added output, while consolidating the industry around leaders [59]. Origin’s recent deals and tech advances aim to ensure it will be one of those leaders capturing the new GMO seed market.
Financial Checkup: Losses Persist, but Cash Infusion Provides Lifeline
Amid the exciting technological and market developments, Origin Agritech’s financial picture presents a mix of challenges and new support. The company is coming off a difficult period earlier in 2025, when it reported declining revenues and a swing to losses. In its latest half-year results (for the six months ended March 31, 2025), Origin’s revenue was $10.1 million, down about 22% from $13.0 million in the same period a year prior [60]. Management partly attributed the drop to a temporary halt of some production lines at its Xinjiang processing plant for upgrades, which reduced output in the short term [61]. Even so, some legacy seed products saw sales declines due to market cycles, and new product lines were only just being introduced, contributing to the revenue dip [62].
Profitability has also been elusive. Origin posted a net loss of $3.6 million for the half-year, a sharp reversal from a small net profit of $0.2 million in the prior-year period [63]. Operating expenses more than doubled year-on-year as the company ramped up R&D and administrative spending [64]. The higher costs reflect Origin’s investments in growth – from research projects to marketing – but they have outpaced sales, putting pressure on the bottom line. By early 2025, Origin’s auditors raised a red flag, issuing an opinion with “a going concern qualification” due to questions about the company’s ability to fund itself going forward. In blunt terms, Origin acknowledged it has “no assured means of raising capital” to meet all future needs and would require additional working capital infusions. This warning signaled significant financial risk, casting doubt on whether the company could continue operating smoothly without new financing.
Fortunately for shareholders, new financing did arrive. The lifeline came in late September when Origin Agritech announced two major investment agreements. CEO Weibin Yan’s $2.4 million personal investment (at $1.20 per share) was a striking show of faith [65] – it’s not every day that a CEO reaches into his own pocket to buy a large stake, effectively doubling down on the company’s future. Alongside Yan’s buy-in, several institutional investors agreed to modify earlier funding deals and inject an additional $1.48 million at $1.20/share as well [66]. In total, Origin secured roughly $3.88 million in fresh equity capital through these transactions. For a company of Origin’s size, this is a meaningful capital boost that extends its cash runway and supports ongoing projects.
Management has stated the new funds will go toward accelerating Origin’s expansion in China’s agri-biotech sector – financing R&D programs, product commercialization, and distribution network growth [67]. “These strategic investments demonstrate the concrete confidence… to adapt to evolving market conditions while maintaining our focus on long-term value creation,” CEO Yan said of the deals [68]. In other words, the insider investment is meant to reassure stakeholders that the leadership is aligned and optimistic about Origin’s prospects. The cash injection also helps alleviate immediate liquidity concerns; it arrived just in time to ease the going-concern cloud hanging over the company. Still, investors should note that Origin’s financial health remains fragile – the company will likely continue needing external capital or sharply higher revenues in the coming years to fund its ambitions. The recent stock price surge could even present an opportunity for Origin to raise additional funds (for example, via a secondary offering) from a position of strength if the price stays elevated.
In terms of valuation, SEED stock now trades around the mid-$1 range, which equates to a market cap near $10–12 million [69]. With trailing twelve-month earnings per share around –$0.91 (a loss) [70], the company has no positive price/earnings ratio. In fact, Origin’s book value is slightly negative (due to past losses), so traditional valuation metrics appear distorted [71]. Essentially, the stock’s value hinges on future potential rather than current profits – investors are betting that Origin’s innovations and market moves will translate into earnings down the line. Any concrete progress (such as hitting a sales inflection from its new corn hybrids or securing a major partnership) could re-rate the stock significantly. Conversely, the tiny market cap and lack of profitability underscore that this stock carries high risk: even minor setbacks or capital needs could dilute shareholders or push the price back down.
Market & Industry Outlook: Tailwinds and Headwinds in Agri-Tech
Origin Agritech’s story is unfolding at a dynamic time in the global agricultural technology industry. On one hand, powerful tailwinds are driving optimism for agri-tech firms. Governments and farmers worldwide are grappling with how to increase crop yields, improve food security, and adapt to climate challenges – and biotechnology is seen as a key part of the solution. In China especially, there is a national priority to boost domestic seed innovation and reduce reliance on imported grain. President Xi Jinping’s administration has emphasized developing a “modern seed industry” as critical to China’s food security strategy [72]. This policy push has led to regulatory reforms that favor companies like Origin. For example, as noted, China is finally moving to allow commercial planting of GM corn after years of bans [73]. The Ministry of Agriculture has streamlined approvals for genetically modified traits, meaning companies that have already cleared safety trials (like Origin’s BBL2-2) can fast-track those traits into existing elite hybrids with just one season of production trials [74]. This dramatically shortens time-to-market for GMO seeds [75]. Such changes effectively open the floodgates for agri-biotech commercialization in China, a sea change that could create multi-billion-dollar opportunities for domestic players [76].
Origin appears well-positioned to surf this wave. It was the first Chinese company to develop and approve a GMO corn (its phytase corn received a biosafety certificate back in 2009), demonstrating a long track record in biotech [77]. Now, with its triple-stack BBL2-2 trait approved and more gene-edited traits in the pipeline, Origin has a technological edge just as the market environment becomes more permissive. The company’s expanding partnerships (with universities, consortia, and seed distributors) also align with China’s push for industry collaboration and consolidation – smaller seed firms teaming up to create national champions capable of competing with multinationals. If Origin can capitalize on the coming GM seed boom in China, it could transform from a niche microcap into a much larger enterprise.
However, there are also significant headwinds and uncertainties in the broader picture. Global agricultural commodity markets are currently under pressure, which can indirectly affect agri-tech investment. Record harvests in Brazil and other producers have led to a glut in key crops like soybeans, pushing prices to multi-year lows [78] [79]. TS2.tech’s agriculture analysis noted that Chinese buyers have shifted nearly entirely to South American soy this year, cutting U.S. imports – one reason U.S. soybean futures are depressed [80] [81]. Lower crop prices can mean farmers have tighter budgets for new seeds or technology, potentially dampening near-term demand for premium seeds in some markets. While corn dynamics differ from soy, the overall farm income outlook could influence how aggressively farmers adopt Origin’s (presumably higher-priced) hybrid and GM seeds.
Geopolitical and trade tensions also loom as a double-edged sword. The recent rally showed how talk of trade restrictions can spark speculative gains for domestic-aligned companies like Origin. But real trade wars or decoupling could have complex impacts – for instance, if China further boosts domestic grain production to rely less on imports, that could benefit seed demand, yet broader economic frictions could hurt investor sentiment. It’s worth noting that some observers remain skeptical that Trump’s “cooking oil” threat has any lasting substance. “The impact is as empty as [Trump’s] threats,” an anonymous trader told Reuters, pointing out that the U.S. had already largely stopped buying that particular commodity from China [82]. In short, while Origin stands to gain from China’s pro-farmer policies, it is also operating in a global context of volatile commodity prices and political uncertainty.
Competition is another factor shaping the outlook. Origin is not alone in chasing China’s seed renaissance. Large Chinese agri-tech companies like Dabeinong and Yuan Longping High-Tech (the latter named after the famous “father of hybrid rice”) are also developing GM corn traits and improved hybrids [83] [84]. These firms have greater resources and are expected to be front-runners in commercialization of GM corn in China [85]. For example, Dabeinong’s DBN9936 GM corn trait is already approved as safe and ready for production trials [86]. If giants like Dabeinong move faster or secure government support, they could capture outsized market share. Origin’s best defense is its innovation speed and partnerships – by innovating cutting-edge traits and teaming with regional players (like Fengtian, and state-affiliated research institutes), Origin can carve out its niche. Nonetheless, the seed industry is consolidating, and smaller companies may need to either grow quickly or consider M&A to survive in the long term.
Finally, from an investment standpoint, expert coverage on SEED is sparse. Major Wall Street analysts do not officially cover Origin Agritech, given its very small size and Chinese base. The stock’s recent surge and volatility underscore that it is driven more by news and sentiment than by analyst price targets. Some independent analysis tools and retail investor forums have turned bullish – for instance, AI-driven models and technical analysis screens have labeled SEED a buy on short-term momentum [87]. However, traditional fundamentals-focused analysts would likely highlight caution: the company has a limited revenue track record and has yet to prove it can achieve profitable scale. In summary, Origin Agritech sits at the intersection of promising macro trends and significant execution challenges. The broader agri-tech outlook is positive, but realizing that potential will require deft navigation of competitive, regulatory, and market forces.
Forecast and Risks: Will SEED Take Root or Wither?
With the recent surge in its stock and a string of hopeful developments, what’s next for Origin Agritech? Professional opinions on SEED’s future remain mixed, balancing the company’s exciting prospects against its vulnerabilities. Here are the key opportunities and risks that will determine Origin’s short- and long-term trajectory:
+ Upside potential: Origin’s advancements in GMO and gene-edited seeds put it at the forefront of a new era in Chinese agriculture. If the company can successfully commercialize its BBL2-2 transgenic corn and other high-tech varieties in the coming year, it could unlock rapid revenue growth. One approved GMO hybrid is expected as soon as late 2025, with more in 2026 [88] – each approval could open sizable new markets. Likewise, the Northeast China expansion and Fengtian partnership may translate into tangible sales boosts by next planting season. An agricultural strategist noted that the strong dealer turnout and new variety approvals give Origin a near-term commercial opening – now it must capitalize on it [89] [90]. China’s push for seed self-sufficiency and yield improvement is a fundamental tailwind in Origin’s favor. In a bullish scenario, Origin could grow into a prime beneficiary of China’s agri-tech modernization, capturing significant market share in corn seeds and perhaps extending into other crops (the company also has rice, canola, and soybean seed programs). If momentum builds, some observers even speculate SEED could uplist or attract a strategic investor/partner given its niche expertise. For now, no formal analyst forecasts are published, but the ingredients for outperformance are on the table if Origin executes well.
– Execution risks: The flip side is that Origin must now prove it can deliver results commensurate with the hype. Converting trial results and dealer excitement into actual seed orders and planting on the ground will be the critical test in the next 6–12 months. “Dependencies and risks include actual seed multiplication, growers’ acceptance, and timely logistics for the coming planting season,” an industry analyst noted, warning that only if those factors align will the showcase interest turn into real sales [91]. Essentially, Origin has to manufacture enough of its new hybrid seeds, get farmers to adopt them, and ensure distribution channels are ready – all within a tight window before the spring planting season. Any slips (e.g. production bottlenecks, insufficient seed supply, lower-than-expected yields on farms, etc.) could derail the anticipated growth spurt. Furthermore, while Origin’s biotech breakthroughs are promising, there is the ongoing hurdle of regulatory approvals for GMO products. China has signaled support, but final approvals for widespread planting of GM corn are still in process. Origin will need to navigate compliance carefully; delays or policy reversals would hurt its plans. “Key dependencies are regulatory compliance for transgenic products, successful field performance data, and clear IP positioning for BBL2-2,” observed a biotech industry analyst, adding that these will determine the scope of commercialization and partner willingness to invest in distribution [92] [93]. In short, a lot has to go right technically and bureaucratically for Origin’s products to reach farmers at scale.
– Financial and market risks: Investors should also remain cautious about Origin’s financial resilience. The recent cash infusion was very helpful, but it was not a huge sum. Origin’s operations likely still consume cash (given its R&D and expansion activities), so the company may require additional funding within a year or two. That could mean further dilution if new shares are issued or debt that adds pressure. The auditor’s warning of no guaranteed capital access looms in the background – essentially a reminder that Origin’s survival is not guaranteed if it cannot keep raising funds during this growth phase. Market conditions will play a role here; should investor sentiment toward Chinese microcaps sour (due to geopolitical events or domestic crackdowns), Origin might find it hard to issue stock without sharply discounting the price. Moreover, SEED’s recent spike itself introduces volatility risk. After a 92% pop, it would not be unusual to see a significant pullback once the initial euphoria fades. Quick profit-taking by traders could drive the price down in the short term, especially since part of the rally was driven by one-off news (the U.S. trade rumor) that doesn’t permanently enhance Origin’s fundamentals. Indeed, seasoned analysts warn that such parabolic spikes often retrace once speculative fever cools [94] [95]. New investors buying in now should be prepared for a bumpy ride and not invest more than they can afford to lose in such a speculative stock.
Outlook: Barring unforeseen setbacks, the next 12–18 months should be eventful for Origin Agritech. Optimistically, we could see milestones like the first commercial sales of GM corn seed in China’s history – potentially supplied by Origin – and the company expanding its revenues through the new regional channels. That narrative could support a higher stock valuation, especially if any hints of profitability emerge. On the other hand, if the regulatory timeline slips or sales disappoint next year, SEED could languish back at previous lows. For now, the company itself is striking an upbeat tone. “We are confident that our investment in advanced breeding and gene-editing technologies will continue to deliver substantial value to our shareholders,” CEO Yan recently affirmed [96]. In the coming quarters, investors will be watching for concrete evidence of that value – in the form of seed orders, licensing deals, or perhaps a strategic partnership with a larger agricultural player.
In summary, Origin Agritech stands at a crossroads of great promise and considerable peril. The excitement around its stock reflects a broader belief that agriculture is entering a biotech renaissance, and Origin could be a homegrown champion in that movement. The company’s innovative seeds, bold partnerships, and insider support paint a compelling growth story, especially against the backdrop of China’s push for agricultural self-reliance. Yet, as a tiny player trying to disrupt a huge industry, Origin must execute almost flawlessly to justify the optimism. The coming year will likely determine if SEED blossoms into a high-growth success or remains a volatile penny stock. For investors and observers, one thing is certain: this “Origin” story will not lack for drama.
Sources: Financial releases and company statements [97] [98]; PR Newswire/StockTitan (Oct 15, 2025) [99] [100]; Benzinga News (Oct 15, 2025) [101] [102]; TS2.tech market analysis [103] [104]; Reuters – China GMO policy context [105].
References
1. www.benzinga.com, 2. www.benzinga.com, 3. www.stocktitan.net, 4. www.stocktitan.net, 5. www.stocktitan.net, 6. www.benzinga.com, 7. www.benzinga.com, 8. www.stocktitan.net, 9. www.benzinga.com, 10. originagritech.com, 11. originagritech.com, 12. originagritech.com, 13. originagritech.com, 14. ts2.tech, 15. ts2.tech, 16. www.benzinga.com, 17. ts2.tech, 18. www.benzinga.com, 19. www.benzinga.com, 20. www.investing.com, 21. www.benzinga.com, 22. www.benzinga.com, 23. www.benzinga.com, 24. ts2.tech, 25. ts2.tech, 26. www.benzinga.com, 27. www.benzinga.com, 28. www.benzinga.com, 29. www.benzinga.com, 30. www.investing.com, 31. www.investing.com, 32. www.stocktitan.net, 33. www.stocktitan.net, 34. www.stocktitan.net, 35. www.stocktitan.net, 36. www.benzinga.com, 37. www.stocktitan.net, 38. www.stocktitan.net, 39. www.stocktitan.net, 40. www.stocktitan.net, 41. originagritech.com, 42. originagritech.com, 43. originagritech.com, 44. originagritech.com, 45. originagritech.com, 46. originagritech.com, 47. originagritech.com, 48. www.benzinga.com, 49. www.benzinga.com, 50. originagritech.com, 51. originagritech.com, 52. originagritech.com, 53. originagritech.com, 54. originagritech.com, 55. www.reuters.com, 56. www.reuters.com, 57. www.reuters.com, 58. www.reuters.com, 59. www.reuters.com, 60. originagritech.com, 61. originagritech.com, 62. originagritech.com, 63. originagritech.com, 64. originagritech.com, 65. originagritech.com, 66. originagritech.com, 67. originagritech.com, 68. originagritech.com, 69. www.benzinga.com, 70. www.investing.com, 71. www.investing.com, 72. www.reuters.com, 73. www.reuters.com, 74. www.reuters.com, 75. www.reuters.com, 76. www.reuters.com, 77. originagritech.com, 78. ts2.tech, 79. ts2.tech, 80. ts2.tech, 81. ts2.tech, 82. ts2.tech, 83. www.reuters.com, 84. www.reuters.com, 85. www.reuters.com, 86. www.reuters.com, 87. www.investing.com, 88. originagritech.com, 89. www.stocktitan.net, 90. www.stocktitan.net, 91. www.stocktitan.net, 92. www.stocktitan.net, 93. www.stocktitan.net, 94. ts2.tech, 95. ts2.tech, 96. www.stocktitan.net, 97. originagritech.com, 98. originagritech.com, 99. www.stocktitan.net, 100. www.stocktitan.net, 101. www.benzinga.com, 102. www.benzinga.com, 103. ts2.tech, 104. ts2.tech, 105. www.reuters.com
